Please login to the form below

Not currently logged in
Email:
Password:

Pharma news in brief

Our weekly round-up of the news in brief

EU should get tough on counterfeits
Tougher measures must be introduced in the European Union to stamp out trading of counterfeit drugs, according to a new report from Professor David Taylor from the University of London School of Pharmacy. Professor Taylor said that while the problem had originally been concentrated in developing countries, the global nature of the pharma industry means that patients everywhere are now at risk. In his report, which was launched at the House of Commons on November 29, he noted that the increased rationing of drugs could fuel the practice of counterfeiting. He has called for tougher legal penalties and better control of internet pharmacies, suggesting that because parallel trade, while not illegal, is difficult to monitor, it is attractive to counterfeiters. The report was funded by a grant from Pfizer.

HIV/AIDS drugs should be available in the workplace
The International Labour Organisation, part of the United Nations, has said that the workplace could offer the best setting to administer anti-retroviral (ARVs) drugs to people with HIV/AIDS. In a report published on World AIDS Day, the agency said that more than 24 million people in the global workforce in 2005 had HIV/AIDS, with 67 per cent living in Africa. The agency believes that ARVs should be made available in the workplace, estimating that 1.8 million more Africans could be alive in 2010 if 80 per cent of the workforce were treated with them.

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...